Evidence map›Paper›PMID 38332979›Full record

ArticlePaediatrics & child health2024

Removing barriers to accessing medical cannabis for paediatric patients.

Richard J Huntsman, Jesse Elliott, Evan Lewis, Charlotte Moore-Hepburn, Jane Alcorn, Holly Mansell, Juan P Appendino, Richard E Bélanger, Scott Corley, Bruce Crooks and 23 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Paediatrics & child health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 12 institutions in 1 country.

Richard J HuntsmanDivision of Pediatric Neurology, Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Jesse ElliottIndependent Researcher, Canadian Collaborative for Childhood Cannabinoid Therapeutics, Winnipeg, Manitoba, Canada.
Evan LewisNeurology Center of Toronto and Division of Pediatric Neurology, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Charlotte Moore-HepburnDepartment of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Jane AlcornCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Holly MansellCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.ORCID https://orcid.org/0000-0002-6405-4775
Juan P AppendinoDivision of Pediatric Neurology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
Richard E BélangerDépartment de Pédiatrie, Faculté de medicine, Université de Laval, Québec, Québec, Canada.
Scott CorleyCannabinoid Research Initiative of Saskatchewan, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Bruce CrooksDivision of Paediatric Hematology/Oncology, Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
AnneMarie M DennyDivision of Pediatric Neurology, Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Yaron FinkelsteinDivisions of Emergency Medicine and Clinical Pharmacology and Toxicology, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Allen FinleyDepartments of Anesthesia and Psychology, Dalhousie University, Halifax, Nova Scotia, Canada.
Ryan FungDepartment of Pediatric Pharmacy, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada.
Andrea GilpinThe Rosalind and Morris Goodman Family Pediatrics Formulation Centre of the CHU Sainte-Justine, Université de Montréal, Montréal, Québec, Canada.
Catherine LitalienDépartement de Pédiatrie, Faculté de Médecine, Université de Montréal, and The Rosalind and Morris Goodman Family Pediatric Formulation Centre of the CHU Sainte Justine, Montréal, Québec, Canada.
Julia JacobsDivision of Pediatric Neurology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
Timothy F OberlanderDepartment of Pediatrics and School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Ashley PalmParent Advocate, Canadian Collaborative for Childhood Cannabinoid Therapeutics, Winnipeg, Manitoba, Canada.
Jacob PalmParent Advocate, Canadian Collaborative for Childhood Cannabinoid Therapeutics, Winnipeg, Manitoba, Canada.
Monika PolewiczDivision of Pediatric Research, Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Declan QuinnDivision of Pediatric Psychiatry, Department of Psychiatry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
S Rod RassekhDivision of Pediatric Hematology/Oncology/BMT, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
Alexander RepetskiParent Advocate, Canadian Collaborative for Childhood Cannabinoid Therapeutics, Winnipeg, Manitoba, Canada.
Michael J RiederDivision of Pediatric Pharmacology, Department of Pediatrics, University of Western Ontario, London, Ontario, Canada.
Amy Robson-McKayDivision of Pediatric Psychiatry, Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Blair SeifertDepartment of Pediatric Pharmacy, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada.
Alan ShackelfordAmarimed of Colorado, Denver, Colorado, USA.
Hal SidenDivision of Palliative Care, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
Michael SzafronSchool of Public Health, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Geert 't JongDepartments of Pediatrics and Pharmacology, University of Manitoba, Winnipeg, Manitoba, Canada.
Régis VaillancourtDepartment of Pediatric Pharmacy, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Lauren E KellyGeorge and Fay Yee Centre for Health Care Innovation and Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Manitoba, Canada.
University of Saskatchewan · CAUniversity of British Columbia · CAUniversity of Toronto · CACentre Hospitalier Universitaire Sainte-Justine · CADalhousie University · CASaskatchewan Health Authority · CAUniversity of Calgary · CAChildren's Hospital of Eastern Ontario · CAChildren's Hospital Research Institute of Manitoba · CAUniversité Laval · CAUniversity of Manitoba · CAWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical cannabis (MC) may offer therapeutic benefits for children with complex neurological conditions and chronic diseases. In Canada, parents, and caregivers frequently report encountering barriers when accessing MC for their children. These include negative preconceived notions about risks and benefits, challenges connecting with a knowledgeable healthcare provider (HCP), the high cost of MC products, and navigating MC product shortages. In this manuscript, we explore several of these barriers and provide recommendations to decision-makers to enable a family-centered and evidence-based approach to MC medicine and research for children.

Indexed as

CanadaHealth CanadaMedical CannabisPaediatric

Identifiers

PMID38332979
PMCPMC10848115
OpenAlexW4362471949

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.